Aminoglycoside-resistant Pseudomonas aeruginosa
% Resistant in 2024
14.7% Resistant
Number of Resistant Isolates of the Total Number of Isolates Tested In 2024
1,030 Resistant
/ 7,004 Tested
% Resistant by Patient Age in 2024
- Pediatric:
- 16.7% Resistant
- Adult:
- 14.6% Resistant
Pathogen Profile
Aminoglycoside-resistant Pseudomonas aeruginosa
Pseudomonas aeruginosa is a common cause of healthcare-associated infections including pneumonia, bloodstream infections, urinary tract infections, and surgical site infections. P. aeruginosa are becoming more resistant to many antibiotics, including aminoglycosides.
- Data Source
- National Healthcare Safety Network (NHSN)
- Current Threat Report
Threat LevelNot Currently Rated
Source: COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2024
- Years Included
- 2011 - 2024
Geographic Locations
Antimicrobial resistance varies by location, driven by a number of factors, including antibiotic use and infection control practices in individual healthcare facilities, the underlying health and age of the patient population, and regional spread from nearby locations.
Percent Aminoglycoside resistance Among Pseudomonas aeruginosa by State Map
This map shows the variation in % aminoglycoside resistance among Pseudomonas aeruginosa causing all event types in 2024.
Percent Aminoglycoside resistance Among Pseudomonas aeruginosa by State
| Location | value |
|---|---|
| Alabama | 14 |
| Alaska | Insufficient Data |
| Arizona | 2.8 |
| Arkansas | 10.4 |
| California | 23.1 |
| Colorado | 6.3 |
| Connecticut | 9.1 |
| Delaware | 84 |
| District of Columbia | 5.3 |
| Florida | 7.4 |
| Georgia | 8.9 |
| Hawaii | 0 |
| Idaho | 0 |
| Illinois | 14.3 |
| Indiana | 5.8 |
| Iowa | 6 |
| Kansas | 10.5 |
| Kentucky | 17.9 |
| Louisiana | 7.8 |
| Maine | 0 |
| Maryland | 9.9 |
| Massachusetts | 16.4 |
| Michigan | 16.7 |
| Minnesota | 9.2 |
| Mississippi | 19.2 |
| Missouri | 40.7 |
| Montana | Insufficient Data |
| Nebraska | 2.7 |
| Nevada | 16.9 |
| New Hampshire | Insufficient Data |
| New Jersey | 4.4 |
| New Mexico | 4.9 |
| New York | 26.5 |
| North Carolina | 14.4 |
| North Dakota | Insufficient Data |
| Ohio | 16.3 |
| Oklahoma | 36.8 |
| Oregon | 0 |
| Pennsylvania | 7.8 |
| Puerto Rico | 34.8 |
| Rhode Island | 64.3 |
| South Carolina | 2.9 |
| South Dakota | 34.8 |
| Tennessee | 21.1 |
| Texas | 7.6 |
| Utah | 0 |
| Vermont | Insufficient Data |
| Virginia | 4.7 |
| Washington | 0.7 |
| West Virginia | 9.7 |
| Wisconsin | 7.2 |
| Wyoming | Insufficient Data |
Percent Aminoglycoside resistance Among Pseudomonas aeruginosa by State List
Geography
| state | value |
|---|---|
| United States | 14.7% |
| Alabama | 14.0% |
| Alaska | No Data |
| Arizona | 2.8% |
| Arkansas | 10.4% |
| California | 23.1% |
| Colorado | 6.3% |
| Connecticut | 9.1% |
| Delaware | 84.0% |
| District of Columbia | 5.3% |
Changes Over Time in Aminoglycoside resistance Among Pseudomonas aeruginosa
This graph displays percent antimicrobial resistance from 2011 to 2024 for all event types. Blank areas of the chart represent 0% resistance, indicating that zero resistant pathogens were reported for the selected year, phenotype, and HAI type. “Insufficient data” indicates that less than 20 pathogens were isolated and tested for resistance.
| Year | % Resistant |
|---|---|
| 2011 | 20 |
| 2012 | 16 |
| 2013 | 17.8 |
| 2014 | 16.1 |
| 2015 | 14.1 |
| 2016 | 13.5 |
| 2017 | 11.3 |
| 2018 | 9.1 |
| 2019 | 8.5 |
| 2020 | 7.9 |
| 2021 | 8.8 |
| 2022 | 7.3 |
| 2023 | 9.7 |
| 2024 | 14.7 |
Healthcare Facility Type
The setting or type of healthcare facility can influence the types of procedures and prevention measures that are related to healthcare-associated infections and antimicrobial resistance.
Aminoglycoside resistance Among Pseudomonas aeruginosa by Hospital Type
This graph displays percent antimicrobial resistance by hospital type in 2024.
Percent resistant Among Pseudomonas aeruginosa by Hospital Type
| Hospital Type | % Resistant |
|---|---|
| General Acute Care Hospitals | 14.8 |
| Long Term Acute Care Hospitals | 15.6 |
| Inpatient Rehabilitation Facilities | 9.8 |
Footnotes
- HAIs include Catheter-associated Urinary Tract Infections (CAUTI), Central Line-associated Bloodstream Infections (CLABSI), and Surgical Site Infections (SSI).
- CI (Confidence Interval) - The national, regional, and state-level data included in Antimicrobial Resistance information are displayed with 95% confidence intervals around the percent resistance, which were calculated using a mid-P exact test and are an indication of precision.
- Map legends are classified using the Jenks Natural Breaks method.